Rewriting the code: examining the promise and responsibility of gene editing

“Scientific progress means little if it does not translate into availability and equity in care.”

On May 13, 2025, Abi Pinchbeck, Commissioning Editor, Cell & Gene Therapy Insights, spoke with Bambi Jo Grilley, Clinical Research and Early Product Development, Center for Cell and Gene Therapy, Baylor College of Medicine, about the evolving landscape of gene editing. This conversation highlights scientific breakthroughs, regulatory challenges, and the urgent need to reduce costs and expand global access to ensure equitable delivery of transformative therapies.

Please enter your email to access content Read now